中國有色金屬學(xué)報(bào)(英文版)
Transactions of Nonferrous Metals Society of China
| Vol. 32 No. 2 February 2022 |
（1. Department of Vascular Surgery, Second Xiangya Hospital, Central South University, Changsha 410011, China;
2. Department of Vascular Surgery, Fuwai Hospital, Chinese Academy of Medical Science, Beijing 100037, China;
3. State Key Laboratory of Powder Metallurgy, Central South University, Changsha 410083, China;
4. School of Microelectronic and Materials Engineering, Guangxi University of Science and Technology, Liuzhou 545006, China）
Abstract:This study aimed to evaluate the feasibility and safety of a novel stent manufactured by metal injection molding (MIM) in clinical practice through animal experiments. Vessel stents were prepared using powder injection molding technology to considerably improve material utilization. The influence of MIM carbon impurity variation on the mechanical properties and corrosion resistance of 316L stainless steel was studied. In vitro cytotoxicity and animal transplantation tests were also carried out to evaluate the safety of MIM stents. The results showed that the performance of 316L stainless steel was very sensitive to the carbon content. Carbon fluctuations should be precisely controlled during MIM. All MIM stents were successfully implanted into the aortas of the dogs, and the MIM 316L stents had no significant cytotoxicity. The novel intravascular stent manufactured using MIM can maintain a stable form and structure with fast endothelialization of the luminal surface of the stent and ensure long-term patency in an animal model. The novel intravascular stent manufactured using MIM demonstrates favorable structural, physical, and chemical stability, as well as biocompatibility, offering promising application in clinical practice.
Key words: vascular stent; metal injection molding; cytotoxicity test; animal experiment; biocompatibility
